[{"Assets_0_Q2_USD":293865000.0,"CommonStockSharesOutstanding_0_Q2_shares":44456659.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24124000.0,"NetIncomeLoss_1_Q2_USD":-13533000.0,"NetIncomeLoss_2_Q2_USD":-26488000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":44450312.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":28248337.0,"StockholdersEquity_0_Q2_USD":254574000.0,"Ticker":"RCUS","CIK":"1724521","name":"ARCUS BIOSCIENCES, INC.","OfficialName":"Arcus Biosciences Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2226368293.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180806"}]